Oct 22 (Reuters) - Dusa Pharmaceuticals will stop developing its Levulan Photodynamic Therapy to treat moderate to severe acne, after the proposed treatment combination failed to show statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback